Villar J, Papageorghiou AT, Pang R, et al: The likeness of fetal growth and newborn size across non-isolated populations in the INTERGROWTH-21st Project: the Fetal Growth Longitudinal Study and Newborn Cross-Sectional Study. Lancet Diabetes Endocrinol 2: 781, 2014
Visser GH, Bilardo CM, Derks JB, et al: he TRUFFLE study; fetal monitoring indications for delivery in 310 IUGR infants with 2 year's outcome delivered before 32 weeks of gestation. Ultrasound Obstet Gynecol November 11t, 2016 [Epub ahead of print]
Waldhoer T, K1ebermass-Schrehof K: he impact of altitude on birth weight depends on further mother-and infant-related factors: a population-based study in an altitude range up to 1600 m in Austria between 1984 and 2013. J Perinatol 35:689, 2015
Walker DM, Marlow N, Upstone L, et al: he Growth Restriction Intervention Trial: long-term outcomes in a randomized trial of timing of delivery in fetal growth restriction. Am J Obstet Gynecol 204(1):34.e1, 2011
Wang D, Hong Y, Zhu L, et al: Risk factors and outcomes of macrosomia in China: a multicentric survey based on birth data. J Matern Fetal Neonatal Med 30:623,t2017
Wiebe HW, Boule NG, Chari R, et al: he efect of supervised prenatal exercise on fetal growth: a meta-analysis. Obstet Gynecol 125: 1185, 2015
Wigby K, D'Epagnier C, Howell S, et al: Expanding the phenotype of Triple X syndrome: a comparison of prenatal versus postnatal diagnosis. Am J Med Genet A 170:2870, 2016
Williams JW: Williams Obstetrics, New York, D. Appleton and Co., 1903
Williams RL: Intrauterine growth curves. Intra-and international comparisons with diferent ethnic groups in California. Prev Med 4: 163, 1975
Williams RL, Creasy RK, Cunningham GC, et al: Fetal growth and perinatal viability in California. Obstet Gynecol 59:624, 1982
Yamamoto R, Ishii K, Shimada M, et al: Signiicance of maternal screening for toxoplasmosis, rubella, cytomegalovirus and herpes simplex virus infection in cases offetal growth restriction. J Obstet Gynaecol Res 39(3):653, 2013
Yang X, Li M, Haghiac M, Catalano PM, et al: Causal relationship between obesity-related traits and TLR4-driven responses at the maternal-fetal interface. Oiabetologia 59:2459, 2016
Yelnik CM, Laskin CA, Porter TF, et al: Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results. Lupus Sci Med 3:e000131, 2016
Zhang J, Merialdi M, Platt LO, et al: Deining normal and abnormal fetal growth: promises and challenges. Am J Obstet Gynecol 202(6):522, 2010 Zhang J, Mikolajczyk R, Grewal J, et al: Prenatal application of the individual ized fetal growth reference. Am J Epidemiol 173(5):539,t2011